OXY-200

N/A

Report date: 2025/01/26 16:32:57
NME

Base Information

Drug NameOXY-200
Drug Alias NameCarbamate-linked Oxy133-ALN monoconjugate (MAX BioPharma)OXY-200
ClassificationSmall molecules > Lipid
Mechanisms of ActionOsteoblasts stimulantsStem cells modulators
TargetsUpdating
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMAX BioPharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesMAX BioPharma Inc
Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A